United States Biotechnology & Medical Research

Trillium Therapeutics Inc (TRIL)

Track

Ticker: TRIL Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
73.45
Quantity 8,753 -42.0%
Value US$1,471,356
1.5
Skvarka Jan President and CEO Executive Director
Transaction date
Sale
Price
171.95
Quantity 66,157 -24.0%
Value US$4,624,469
1.5
Skvarka Jan President and CEO Executive Director
Transaction date
Sale
Price
171.80
Quantity 92,512 +1.1%
Value US$521,932
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
10.82
Quantity 3,646 -100.0%
Value US$39,450
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
11.97
Quantity 2,917 -100.0%
Value US$34,916
Petrova Penka Chief Development Officer Officer
Transaction date
Planned sale
Price
11.08
Quantity 5,312 -100.0%
Value US$58,857
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
10.11
Quantity 3,646 -100.0%
Value US$36,861
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
14.12
Quantity 584 -100.0%
Value US$8,248
Petrova Penka Chief Development Officer Officer
Transaction date
Planned sale
Price
14.17
Quantity 508 -100.0%
Value US$7,200
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.65
Quantity 6,563 -100.0%
Value US$83,022
Petrova Penka Chief Development Officer Officer
Transaction date
Planned sale
Price
12.65
Quantity 5,312 -100.0%
Value US$67,197
1.5
Skvarka Jan President and CEO Executive Director
Transaction date
Planned sale
Price
15.03
Quantity 19,581 -100.0%
Value US$294,279
1.5
Skvarka Jan President and CEO Executive Director
Transaction date
Planned sale
Price
15.04
Quantity 5,419 -100.0%
Value US$81,508
Petrova Penka Chief Development Officer Officer
Transaction date
Planned sale
Price
15.21
Quantity 508 -100.0%
Value US$7,725
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.20
Quantity 584 -100.0%
Value US$8,879
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.51
Quantity 2,917 -100.0%
Value US$45,230
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.82
Quantity 5,600 -100.0%
Value US$88,575
Parsons James T. Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.79
Quantity 8,505 -100.0%
Value US$134,271
Petrova Penka Chief Development Officer Officer
Transaction date
Planned sale
Price
15.50
Quantity 2,604 -100.0%
Value US$40,365
Petrova Penka Chief Development Officer Officer
Transaction date
Planned sale
Price
14.71
Quantity 2,708 -100.0%
Value US$39,843
Uger Robert Chief Scientific Officer Officer
Transaction date
Planned sale
Price
14.75
Quantity 3,646 -100.0%
Value US$53,782
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-09 2021-06-07 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
8,753 -42.0%
73.45
US$1,471,356 		8,753 -42.0% 73.45 US$1,471,356
2021-05-13 2021-05-12 S Sale
1.5
Skvarka Jan

President and CEO

Executive Director
66,157 -24.0%
171.95
US$4,624,469 		66,157 -24.0% 171.95 US$4,624,469
2021-05-13 2021-05-11 S Sale
1.5
Skvarka Jan

President and CEO

Executive Director
92,512 +1.1%
171.80
US$521,932 		92,512 +1.1% 171.80 US$521,932
2021-04-09 2021-04-07 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
3,646 -100.0%
10.82
US$39,450 		3,646 -100.0% 10.82 US$39,450
2021-03-15 2021-03-12 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
2,917 -100.0%
11.97
US$34,916 		2,917 -100.0% 11.97 US$34,916
2021-03-12 2021-03-10 PlS Planned sale
Petrova Penka

Chief Development Officer

Officer
5,312 -100.0%
11.08
US$58,857 		5,312 -100.0% 11.08 US$58,857
2021-03-10 2021-03-08 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
3,646 -100.0%
10.11
US$36,861 		3,646 -100.0% 10.11 US$36,861
2021-02-10 2021-02-09 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
584 -100.0%
14.12
US$8,248 		584 -100.0% 14.12 US$8,248
2021-02-10 2021-02-09 PlS Planned sale
Petrova Penka

Chief Development Officer

Officer
508 -100.0%
14.17
US$7,200 		508 -100.0% 14.17 US$7,200
2021-02-10 2021-02-08 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
6,563 -100.0%
12.65
US$83,022 		6,563 -100.0% 12.65 US$83,022
2021-02-10 2021-02-08 PlS Planned sale
Petrova Penka

Chief Development Officer

Officer
5,312 -100.0%
12.65
US$67,197 		5,312 -100.0% 12.65 US$67,197
2021-01-15 2021-01-14 PlS Planned sale
1.5
Skvarka Jan

President and CEO

Executive Director
19,581 -100.0%
15.03
US$294,279 		19,581 -100.0% 15.03 US$294,279
2021-01-15 2021-01-13 PlS Planned sale
1.5
Skvarka Jan

President and CEO

Executive Director
5,419 -100.0%
15.04
US$81,508 		5,419 -100.0% 15.04 US$81,508
2021-01-13 2021-01-11 PlS Planned sale
Petrova Penka

Chief Development Officer

Officer
508 -100.0%
15.21
US$7,725 		508 -100.0% 15.21 US$7,725
2021-01-13 2021-01-11 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
584 -100.0%
15.20
US$8,879 		584 -100.0% 15.20 US$8,879
2021-01-12 2021-01-08 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
2,917 -100.0%
15.51
US$45,230 		2,917 -100.0% 15.51 US$45,230
2021-01-12 2021-01-08 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
5,600 -100.0%
15.82
US$88,575 		5,600 -100.0% 15.82 US$88,575
2021-01-12 2021-01-08 PlS Planned sale
Parsons James T.

Chief Financial Officer

Officer
8,505 -100.0%
15.79
US$134,271 		8,505 -100.0% 15.79 US$134,271
2021-01-12 2021-01-08 PlS Planned sale
Petrova Penka

Chief Development Officer

Officer
2,604 -100.0%
15.50
US$40,365 		2,604 -100.0% 15.50 US$40,365
2021-01-11 2021-01-07 PlS Planned sale
Petrova Penka

Chief Development Officer

Officer
2,708 -100.0%
14.71
US$39,843 		2,708 -100.0% 14.71 US$39,843
2021-01-11 2021-01-07 PlS Planned sale
Uger Robert

Chief Scientific Officer

Officer
3,646 -100.0%
14.75
US$53,782 		3,646 -100.0% 14.75 US$53,782
Explore more

More insider trading research around Trillium Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America